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ABSTRACT 
This study was aimed to fabricate and evaluate a combination of Artemether and Lumefantrine as tablets and to make Artemether in 
sustained form so as to prolong its elimination time. Artemether was formulated in form of microspheres by solvent evaporation 
technique and was then formed into the tablet along with the Lumefantrine. Artemether microspheres were prepared and compressed 
into compressible tablet by direct compression process using the compressible excipients along with Lumefantrine, and was further 
evaluated for various parameters such as hardness, thickness, weight variation, friability, drug content, in vitro drug release and 
stability. 
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INTRODUCTION: 
Malaria is one of the most important and scourge 
infectious diseases in developing areas of the world. It is 
estimated that 300-500 million cases of malaria occur 
each year resulting in 750,000- 2 million deaths (World 
malaria situation, 1994). It is transmitted by the bite of 
female mosquito (Anopheles). Mainly four major 
species of Plasmodium are found in humans 
(P.falciparum, P.vivax, P.ovale and P.malariae)
1
. 
Effective treatment is dependent on the use of an 
efficacious anti malarial that is taken according to an 
optimized regimen. Artemisinin-based combination 
treatments (ACTs) have the most potent and rapid onset 
of anti-parasitic activity of any anti-malarial drug 
available today and are active against all Plasmodium 
species that infect humans
2
. Efficacy is determined by 
the drug partnering the Artemisinin derivatives and 
Artemether-Lumefantrine is one such drug combination. 
The rationale behind this combination is that artemether 
initially provides rapid symptomatic relief by reducing 
the number of parasites present before lumefantrine 
eliminates any residual parasites. 
MATERIALS AND METHODS: 
Materials 
Artemether (ART), Lumefantrine (LUM), Ethyl 
Cellulose (EC), Polyvinyl alcohol (PVA), 
Dichloromethane (DCM),  Distilled water, 
Microcrystalline cellulose (MCC), Sodium Starch 
Glycolate (SSG), Croscarmellose Sodium (CCS), 
Magnesium Stearate, Colloidal Silicon Dioxide. 
Preparation of Artemether Microspheres 
Artemether microspheres were obtained by solvent 
evaporation technique Polymer was dissolved in 
dichloromethane and then the drug was added to the 
above solution. This solution was injected into the PVA 
solution maintained at variable speed using mechanical 
stirrer. Stirring was continued until all the 
dichloromethane evaporated. The formed microspheres 
were collected by filtration andwashed with n-Hexane 
and dried 
3, 4
. 
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Table 1: Formulation codes of Artemether-EC Microspheres 
Formulation 
Codes 
Drug 
(Artemether) 
(mg) 
Polymer 
(Ethyl Cellulose) 
(mg) 
Solvent 
(DCM) 
(ml) 
Medium 
(PVA) 
(%) 
Stirring 
rate 
(rpm) 
M1 500 1000 20 0.5 200 
M2 500 1000 20 0.5 400 
M3 500 1000 20 0.5 600 
M4 500 1250 20 0.5 200 
M5 500 1250 20 0.5 400 
M6 500 1250 20 0.5 600 
M7 500 1000 20 0.3 200 
M8 500 1000 20 0.3 400 
M9 500 1000 20 0.3 600 
M10 500 1250 20 0.3 200 
M11 500 1250 20 0.3 400 
M12 500 1250 20 0.3 600 
M13 500 1000 20 0.1 200 
M14 500 1000 20 0.1 400 
M15 500 1000 20 0.1 600 
M16 500 1250 20 0.1 200 
M17 500 1250 20 0.1 400 
M18 500 1250 20 0.1 600 
 
Table 2: Formulation codes of tablets containing ART Microspheres and LUM 
FC ART 
microsphere  
LUM MCC SSG CCS Mag. 
Stearate 
Colloidal 
SiO2 
MT1 20 120 107 3 - 7 3 
MT2 20 120 105.5 4.5 - 7 3 
MT3 20 120 104 6 - 7 3 
MT4 20 120 102.5 7.5 - 7 3 
MT5 20 120 101 9 - 7 3 
MT6 20 120 99.5 10.5 - 7 3 
MT7 20 120 98 12 - 7 3 
MT8 20 120 96.5 13.5 - 7 3 
MT9 20 120 95 15 - 7 3 
MT10 20 120 97 - 3 7 3 
MT11 20 120 95.5 - 4.5 7 3 
MT12 20 120 94 - 6 7 3 
MT13 20 120 92.5 - 7.5 7 3 
MT14 20 120 91 - 9 7 3 
MT15 20 120 89.5 - 10.5 7 3 
MT16 20 120 88 - 12 7 3 
MT17 20 120 86.5 - 13.5 7 3 
MT18 20 120 85 - 15 7 3 
 
Characterization of microspheres 
Prepared microsphere should be characterized by 
following tests such as, Particle size analysis, surface 
Morphology, determination of Percentage yield of 
microspheres, determination of flow properties of 
microspheres, drug entrapment efficiency, In vitro 
release studies of microspheres and effect of different 
formulation variables on various evaluation parameters. 
Formulation of Tablets containing microspheres 
Tablets of ART microspheres and LUM were prepared 
by direct compression technique. The corresponding 
amount of ART microspheres equivalent to 20 mg drug, 
lumefantrine, MCC and superdisintegrants were 
accurately weighed and blended. Thereafter the 
corresponding amount of magnesium stearate and 
colloidal silicon dioxide were added to the mixture. The 
mixture was allowed for direct compression into tablets 
weighing 300mg using a tablet punching machine with 8 
mm flat faced punches.  
Characterization of tablets 
Formulated tablet should be evaluated by following test 
such as, thickness, diameter, hardness, friability, weight 
variation, drug content, microscopic evaluation of 
tableted microspheres and In vitro release of 
Lumefantrine&Artemether from tablets 
 
Vinchurkar et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2017; 7(7):4-7                       
ISSN: 2250-1177                                                                                  [6]                                                                             CODEN (USA): JDDTAO 
RESULTS AND DISCUSSIONS: 
Table 3: Evaluation parameters of microspheres 
Formulation 
Codes 
Percentage Yield 
(%) 
Entrapment 
Efficiency (%) 
Particle Size 
(µm) 
Cumulative 
Release (%) 
M1 84.87 66.20 18.45 63.03 
M2 79.40 60.49 18.30 68.38 
M3 94.00 54.06 15.00 71.65 
M4 90.28 70.57 23.12 57.85 
M5 86.00 67.42 19.10 61.95 
M6 70.34 63.23 16.92 69.19 
M7 88.33 67.81 21.00 69.01 
M8 92.27 61.15 21.00 71.79 
M9 91.73 52.81 14.80 76.72 
M10 86.68 73.31 22.77 63.38 
M11 86.91 69.98 21.87 70.14 
M12 66.63 66.98 19.35 74.48 
M13 86.00 70.15 26.42 72.51 
M14 84.06 68.39 23.80 76.45 
M15 76.67 63.86 20.00 84.87 
M16 71.88 74.42 26.10 71.02 
M17 88.91 71.26 22.45 75.11 
M18 90.11 67.07 18.95 79.48 
 
The morphology of the prepared batches of Artemether 
microspheres was evaluated by Scanning Electron 
Microscopy (SEM). Scanning Electron micrographs of 
the microspheres are shown in figure at different 
magnifications of 70x, 100x and 10000x revealing the 
spherical and smooth surface.  
  
 
Figure1: Entrapment efficiency (%) of microspheres 
    
Figure 2: Particle size of microspheres                                   Figure 3: Percentage yield (%) of microspheres 
 
Figure 4: Scanning Electron Micrograph at 70, 100 and 10000 magnification 
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In vitro dissolution studies of art 
 
Figure 5: %CDR (ART) of MT1-MT5                            Figure 6: % CDR (ART) of MT6 - MT10 
Figure depicts the release rate of ART from the tableted microspheres for all the formulations. At 10
th
 hours release rate 
of drug was between 61.24% - 86.92%. M15 formulation shows the maximum release and M4 shows the minimum 
release. It depicts that the release of ART either from microspheres or from the tableted microspheres was found to be 
relatively near about same. A slight increase is observed in the release from tableted microspheres.  
 
Figure 7: %CDR (ART) of MT11-MT14                            Figure 8: % CDR (ART) of MT15- MT18 
 
CONCLUSION: 
Sustained release microspheres of ART were 
successfully prepared using EC by solvent evaporation 
technique and after successfully incorporating ART into 
microspheres, this study aimed to obtain tablets as a 
final oral dosage form. ART microspheres along with 
LUM were formulated into tablets by direct compression 
technique using the excipients. Hence the present work 
suggest that, ART which has the lower half life and 
eliminates quickly from the body, when loaded with 
ethyl cellulose in form of microspheres and tableted 
along with LUM results in sustained release of drug in 
malaria.  Therefore, ART and LUM in combination 
minimizes development of resistance as the malaria 
parasites are never exposed to artemether alone, so are 
considered as the best combination for treatment of 
malaria. 
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